Jiangsu Hengrui Medicine
600276.SS
$5.76
Share price
-1.58%
Change (1 day)
-18.64%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Total assets
Total assets on the balance sheet as of September 2023 : $5.98 B
According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are $5.98 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $6.14 B | -0.34% |
| 2021-12-31 | $6.16 B | 15.73% |
| 2020-12-31 | $5.32 B | 34.99% |
| 2019-12-31 | $3.94 B | 20.51% |
| 2018-12-31 | $3.27 B | 18.05% |
| 2017-12-31 | $2.77 B | 34.36% |
| 2016-12-31 | $2.06 B | 16.34% |
| 2015-12-31 | $1.77 B | 20.87% |
| 2014-12-31 | $1.46 B | 23% |
| 2013-12-31 | $1.19 B | 26.24% |
| 2012-12-31 | $0.94 B | 23.29% |
| 2011-12-31 | $0.76 B | 30.12% |
| 2010-12-31 | $0.58 B | 34.19% |
| 2009-12-31 | $0.43 B | 32.69% |
| 2008-12-31 | $0.33 B | 17.28% |
| 2007-12-31 | $0.28 B | 49.97% |
| 2006-12-31 | $0.18 B | 18.09% |
| 2005-12-31 | $0.15 B | 4.89% |
| 2004-12-31 | $0.15 B | -13.46% |
| 2003-12-31 | $0.17 B | 20.58% |
| 2002-12-31 | $0.14 B | 7.64% |
| 2001-12-31 | $0.13 B |